Katekolaminerg polymorf ventrikulaer takykardi er en sjaelden arvelig hjertesygdom
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Katekolaminerg polymorf ventrikulaer takykardi er en sjaelden arvelig hjertesygdom. / Holst, Anders Gaarsdal; Tfelt-Hansen, Jacob; Olesen, Morten S; Theilade, Juliane; Winkel, Bo G; Christensen, Alex H; Bundgaard, Henning; Haunsø, Stig; Svendsen, Jesper Hastrup.
I: Ugeskrift for Laeger, Bind 172, Nr. 31, 02.08.2010, s. 2140-4.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Katekolaminerg polymorf ventrikulaer takykardi er en sjaelden arvelig hjertesygdom
AU - Holst, Anders Gaarsdal
AU - Tfelt-Hansen, Jacob
AU - Olesen, Morten S
AU - Theilade, Juliane
AU - Winkel, Bo G
AU - Christensen, Alex H
AU - Bundgaard, Henning
AU - Haunsø, Stig
AU - Svendsen, Jesper Hastrup
PY - 2010/8/2
Y1 - 2010/8/2
N2 - Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease, which can lead to life-threatening ventricular arrhythmias in patients with a structurally normal heart. The age of onset is usually between two and 12 years and the initial symptom is frequently syncope or cardiac arrest. The arrhythmias are usually triggered by exercise or emotional affection. The diagnosis is often made using exercise electrocardiogram, which typically triggers arrhythmias. The treatment consists of beta blockers, frequently in combination with implantation of a cardioverter-defibrillator.
AB - Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease, which can lead to life-threatening ventricular arrhythmias in patients with a structurally normal heart. The age of onset is usually between two and 12 years and the initial symptom is frequently syncope or cardiac arrest. The arrhythmias are usually triggered by exercise or emotional affection. The diagnosis is often made using exercise electrocardiogram, which typically triggers arrhythmias. The treatment consists of beta blockers, frequently in combination with implantation of a cardioverter-defibrillator.
M3 - Tidsskriftartikel
VL - 172
SP - 2140
EP - 2144
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 31
ER -
ID: 34042280